Core Framework & Diagram Why Does Infection Cause Persistent Fatigue?

Post-infectious syndrome is not unique to COVID-19. Its incidence after EBV infection is approximately ten to twelve percent; after Lyme disease approximately ten to fifteen percent of patients have persistent symptoms; also reported after severe influenza and pneumonia. COVID-19 only brought this phenomenon into public view due to the huge number of infections, and pushed large amounts of research. COVID-19 post-infectious syndrome incidence is higher than most other viral infections (approximately ten to fifteen percent report symptoms persisting over three months), possibly related to its effects on the blood-brain barrier, capacity for neuroinflammation, and special mechanisms for triggering autoimmune reactions.

Brain fog (cognitive fog) in Long COVID has an independent neurobiological basis separate from fatigue. Research found Long COVID patients reporting brain fog performed significantly worse on standardized cognitive tests (working memory, attention, processing speed) than uninfected controls — and this difference doesn't fully correlate with their reported fatigue level. PET-scan-detected brain microglial activation (neuroinflammation) is more pronounced in brain fog patients, suggesting an independent neurobiological mechanism rather than just 'too tired to think clearly.'

For most people, yes. Research shows most mild-to-moderate post-infection syndromes show significant improvement within three to six months; most people can basically recover within six to twelve months. But a portion of people (approximately ten to twenty percent of Long COVID patients) have symptoms persisting over a year. Factors affecting prognosis: infection severity, whether persistent low-grade inflammation exists, age (recovery is slower after forty), and whether behaviors triggering vicious cycles were avoided (like 'overdoing it when feeling better').

Has some theoretical basis and preliminary evidence; safety is good, but evidence isn't yet sufficient. CoQ10 is an important component of the mitochondrial respiratory chain, participating in ATP synthesis. The logic for post-infectious syndrome: supplementing CoQ10 may support damaged mitochondria's energy production efficiency, reducing post-exertional malaise. Several small studies show CoQ10 (300–600mg/day) has some benefit for chronic fatigue syndrome patients, but large randomized controlled trials aren't yet adequate. As a safe adjunct supplement (not replacing basic lifestyle management), worth trying.